AlphaYou
Overview
Smart-money signal on INDV this 14d.
Key stats
Sep 5- Open
- $34.74
- 52-wk high
- $42.81
- High
- $35.31
- 52-wk low
- $22.22
- Low
- $34.55
- Prev close
- $34.83
- Mkt cap
- $4.11B
- P/E
- 12.5x
- Volume
- 1.02M
- Fwd P/E
- 9.0x
- Beta
- 1.14
- P/S
- 3.1x
- P/B
- 145.3x
- Profit margin
- +26.8%
- Op margin
- +46.9%
- ROE
- +12.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 18.6% above what analysts expected.
Earnings per share
$0.97 expected
Reports Oct 29, 2026, in 54 days
EPS expected
$1.09 to $1.15
Revenue expected
2 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $314.0M | $358.0M | $317.0M | $343.0M |
| Cost of what it sold | $62.0M | $64.0M | $40.0M | $49.0M |
| Gross profit | $252.0M | $294.0M | $277.0M | $294.0M |
| What it spent | ||||
| Research and development | $20.0M | $17.0M | $16.0M | $12.0M |
| Sales and admin | $155.0M | $223.0M | $124.0M | $122.0M |
| Other operating costs | -$22.0M | -$68.0M | — | — |
| Total operating expenses | $153.0M | $172.0M | $140.0M | $134.0M |
| What was left | ||||
| Operating profit | $99.0M | $122.0M | $137.0M | $160.0M |
| Interest on debt | $12.0M | $6.0M | $7.0M | $2.0M |
| Profit before tax | $37.0M | $81.0M | $115.0M | $160.0M |
| Tax | -$5.0M | -$21.0M | $26.0M | $38.0M |
| Net profit | $42.0M | $102.0M | $89.0M | $122.0M |
| EBITDA | $54.0M | $92.0M | $124.0M | $162.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Leans bullishAug 31Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
BullishAug 31Indivior stock holds near $36 after a buyback run
Leans bullishAug 25Indivior stock holds firm after record quarter and Supernus merger plan
BullishAug 24Reasons Why Investors Should Consider Betting on Indivior Stock
BullishAug 23Indivior stock holds firm as Supernus merger and higher 2026 EBITDA outlook reshape the story
NeutralAug 22Is Indivior Stock a Buy After Higher 2026 Guidance?
BullishAug 22
Macro
22 macro signals shaping INDV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results